The optimal effect site concentration of target-controlled infusion with propofol in gynecological surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220207005

Enrollment

Registered

2022-02-07

Start date

2021-07-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The optimal effect-site propofol concentration (Ce) during maintenance and in each stage of anesthesia in Thai female patients undergoing gynecological surgery Effect site concentration propofol TCI Eleveld model

Interventions

Patients undergoing open abdomen and laparoscopic gynecological surgery

Treatment

Gynecological surgery patients

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years, 2. ASA classification 1-3

Exclusion criteria

Exclusion criteria: 1) Abnormal liver function 2) Uncontrolled cardiovascular diseases 3) Inability to understand and communication 4) Obesity (BMI> 30) 5) Pregnancy 6) Drug abuse 7) Allergy to medications used in the protocol 8) Risk difficult intubation 9) Surgery duration > 6 hours

Design outcomes

Primary

Measure	Time frame
effect-site concentration at maintenance of anesthesia target-controlled infusion	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactHataichanok Manurat

Faculty of medicine, Chiang Mai university

noktaew66@gmail.com0832964324

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026